Triacsin C

Triacsin C is an inhibitor of long fatty acyl CoA synthetase that has been isolated from Streptomyces aureofaciens.

Uses your system voice; voice and rate in settings.

Snapshot

≈ 1 min read

Names in other languages

No names in other languages are held for this entry yet.

Article bodies are English and are not machine-translated. A name in another language is not a translation of the article.

Triacsin C is an inhibitor of long fatty acyl CoA synthetase that has been isolated from Streptomyces aureofaciens. It blocks β-cell apoptosis, induced by fatty acids (lipoapoptosis) in a rat model of obesity. In addition, it blocks the de novo synthesis of triglycerides, diglycerides, and cholesterol esters, thus interfering with lipid metabolism.

In addition, triacsin C is a vasodilator. Inhibition of lipid metabolism reduces/removes lipid droplets from HuH7 cells. In hepatitis C–infected HuH7 cells, this reduction/removal of lipid droplets by triacsin C correlates with a reduction in virion assembly and infectivity.

General chemical description

Triacsin C belongs to a family of bacterial secondary metabolites all having an 11-carbon chain with a common N-hydroxytriazene moiety at the terminus. Due to the N-hydroxytriazene group, triacsin C has acidic properties and may be considered a polyunsaturated fatty acid analog. Triacsin C was discovered by a group led by Keizo Yoshida in 1982 from a culture of the actinobacteria now known as Kitasatospora aureofaciens.

See also

Fatty acid degradation#Activation_and_transport_into_mitochondria Fatty acyl CoA synthetase

Text derived from https://en.wikipedia.org/w/index.php?oldid=1281633027 under CC BY-SA 4.0; modifications have been made.

Sources cited in this revision

1 named source(s) extracted from the cited revision. A source with no author is shown by its publication; nothing is invented.